Any condition resulting in biallelic expression, including paternal uniparental disomy and loss of imprinting, brings about IGF2 mRNA overexpression associated with increased risk of WT, hepatoblastoma, rhabdomyosarcoma, and neuroblastoma13–15. Here, IGF2 is linked to hepatoblastoma.